MEdical Treatment in Idiopathic Ventricular Fibrillation Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 218 participants.

Also called NCT07405229

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 218 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07405229
  • EudraCT 2018-001683-37
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07405229. Randomized; single masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2032-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
Acronym
RIME-IVF
Condition
Idiopathic Ventricular Fibrillation
Condition
Cardiac Arrest, Out-Of-Hospital
Intervention (Drug)
Beta-blocker treatment group
Lead sponsor
Bo Gregers Winkel (class: other)
Collaborator
Novo Nordisk Foundation (class: other)
Collaborator
Danish Heart Foundation (class: other)

Record details

Record id
cardio:ct-nct07405229
Content hash
14f5aba98cd4a624d5b05208515fa91e6b4eead1019a4a6d435fec735b96337c